US 12168681
Il-2 variants with reduced binding to IL-2 receptor alpha and uses thereof
granted A61KA61K38/00A61K38/2013
Quick answer
US patent 12168681 (Il-2 variants with reduced binding to IL-2 receptor alpha and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Dec 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Dec 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K38/00, A61K38/2013, A61K45/06, A61P